Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
ENCORE - Originally aired November 7, 2024 There’s a lot of attention right now around…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…
It’s a troubling situation: Nearly one in three high school students report persistent feelings of…
Description: Dr. Igor Koralnik, the co-director of Northwestern Medicine’s Comprehensive COVID-19 Center, is one of…
Dr. Leana Wen, a health news commentator for The Washington Post and CNN, is known…
Very early this morning the U.S. House passed a bill that would result in more…